Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling-Reference-Cited by-同舟云学术

Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling

Published:2020-11-05 Issue:6 Volume:121 Page:3352-3389
ISSN:0009-2665
Container-title:Chemical Reviews
language:en
Short-container-title:Chem. Rev.

Author:

Craig Morgan¹²^ORCID,Jenner Adrianne L.¹²,Namgung Bumseok³⁴^ORCID,Lee Luke P.³⁴^ORCID,Goldman Aaron³⁴^ORCID

Affiliation:

1. Department of Mathematics and Statistics, University of Montreal, Montreal, Quebec H3C 3J7, Canada

2. Sainte-Justine University Hospital Research Centre, Montreal, Quebec H3S 2G4, Canada

3. Division of Engineering in Medicine, Brigham and Women’s Hospital, Boston, Massachusetts 02115, United States

4. Department of Medicine, Harvard Medical School, Boston, Massachusetts 02139, United States

Funder

Fonds de Recherche du Qu?bec - Sant?

Breast Cancer Alliance

Government of Canada

Centre for Applied Mathematics in Biosciences and Medicine

Publisher

American Chemical Society (ACS)

Subject

General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.chemrev.0c00356

Reference335 articles.

1. A call to arms: Unifying the fight against resistance

2. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

3. Cure of Hodgkin's Disease

4. Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating frontiers: a holistic, quantum and evolutionary approach to conquering cancer through systems biology and multidisciplinary synergy;Frontiers in Oncology;2024-08-19

2. Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review;Translational Oncology;2024-07

3. Recent advanced lipid-based nanomedicines for overcoming cancer resistance;Cancer Drug Resistance;2024-06-21

4. Harnessing machine learning potential for personalised drug design and overcoming drug resistance;Journal of Drug Targeting;2024-06-13

5. Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer;Journal of Nanobiotechnology;2024-05-14